Paddington Life Sciences has welcomed Medtronic, a global leader in healthcare technology, to its diverse community of partners. The organisation brings together entities from the NHS, academia, industry, and the public sector to foster collaboration, enhance patient outcomes, and drive inclusive growth.
Existing partners within the Paddington Life Sciences network include Imperial College Healthcare NHS Trust, Imperial College London, and Westminster City Council, alongside a growing number of commercial healthcare and technology firms dedicated to delivering tangible benefits to communities across Paddington and North West London.
Medtronic, renowned for its work in medical devices across cardiovascular care, neuroscience, and surgical technology, contributes significant expertise in medical technology, data-driven care, and patient outcomes. The company serves patients and healthcare systems in over 150 countries with a mission to alleviate pain, restore health, and extend life through biomedical innovation.
Dr Suki Balendra, Director of Strategic Partnerships for Paddington Life Sciences, expressed enthusiasm for the new partnership. "We are delighted to welcome Medtronic to the Paddington Life Sciences community," she stated. "Medtronic's global leadership in medical technology and its strong focus on innovation, data and patient outcomes align closely with our ambition to build a world-leading life sciences cluster in Paddington. Their presence strengthens our collective ability to translate cutting-edge science into real-world impact for patients across North West London and beyond."
Dr Balendra added, "At Paddington Life Sciences, we are committed to fostering meaningful collaboration between the NHS, academia, industry and the communities we serve. Medtronic brings deep expertise and a shared commitment to improving access, equity and outcomes in healthcare, which will be invaluable as we continue to develop our workstreams across clinical research, skills, and inclusive innovation."
“"We look forward to working closely with Medtronic and our wider partners to accelerate innovation, support more diverse participation in research, and deliver tangible benefits for patients and local communities."
Dr Matthew Williams-Gray, Senior Director, Enterprise Accounts and Integrated Health Solutions and Country Lead, UK & Ireland, at Medtronic, commented on the significance of the collaboration. "Joining Paddington Life Sciences as a leading global medtech partner marks an exciting opportunity for Medtronic and reflects a shared commitment to advancing health innovation," he said.
"The strength of this ecosystem lies in its ability to bring together the NHS, academia and industry to exchange ideas, share expertise and explore new possibilities together," Dr Williams-Gray continued. "Building on our longstanding partnership with Imperial College Healthcare NHS Trust, we're proud to deepen our collaboration across the cluster and support efforts that help advance healthcare and create lasting value for patients and local communities."
